The global Women's Health Drugs market is projected to grow from US$ 33270 million in 2023 to US$ 41620 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.8% during the forecast period.

Women's Health Drugs Market

This report focuses on pharmaceutical products for female-related diseases.

The main companies of Global Women's Health include Amgen, Bayer, Merck KGaA, etc. These top three companies hold a market share about 20%. Europe and North America are the leading production regions in the world. The product is mainly used in contraceptive pills.

Report Includes:

This report presents an overview of global market for Women's Health Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Women's Health Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Women's Health Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Women's Health Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Women's Health Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Women's Health Drugs sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including AbbVie Inc, Allergan Plc, Bayer AG, GlaxoSmithKline, Merck & Co., Pfizer and Therapeutics MD, etc.

Scope of Women's Health Drugs Market Report

Report Metric	Details
Report Name	Women's Health Drugs Market
Accounted market size in 2023	US$ 33270 million
Forecasted market size in 2029	US$ 41620 million
CAGR	3.8
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Postmenopausal Osteoporosis Drug Infertility Drug Endometriosis Drug Contraceptives Drug Menopause Drug Polycystic Ovary Syndrome Drug Other
Segment by Application	Little Girls Young Women Elderly Women
Segment by Region	US & Canada U.S. Canada China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Europe Germany France U.K. Italy Russia Middle East, Africa, Latin America Brazil Mexico Turkey Israel GCC Countries
By Company	AbbVie Inc, Allergan Plc, Bayer AG, GlaxoSmithKline, Merck & Co., Pfizer, Therapeutics MD
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Women's Health Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Women's Health Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Women's Health Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Women's Health Drugs Market growing?

Ans: The Women's Health Drugs Market witnessing a CAGR of 3.8 during the forecast period 2023-2029.

What is the Women's Health Drugs Market size in 2029?

Ans: The global Women's Health Drugs market is projected to grow from US$ 33270 million in 2023 to US$ 41620 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.8% during the forecast period.

What is the market share of major companies in Women's Health Drugs Market?

Ans: These top three companies hold a market share about 20%.

Who are the main players in the Women's Health Drugs Market report?

Ans: The main players in the Women's Health Drugs Market are AbbVie Inc, Allergan Plc, Bayer AG, GlaxoSmithKline, Merck & Co., Pfizer, Therapeutics MD

What are the Application segmentation covered in the Women's Health Drugs Market report?

Ans: The Applications covered in the Women's Health Drugs Market report are Little Girls, Young Women, Elderly Women

What are the Type segmentation covered in the Women's Health Drugs Market report?

Ans: The Types covered in the Women's Health Drugs Market report are Postmenopausal Osteoporosis Drug, Infertility Drug, Endometriosis Drug, Contraceptives Drug, Menopause Drug, Polycystic Ovary Syndrome Drug, Other

1 Study Coverage

1.1 Women's Health Drugs Product Introduction

1.2 Market by Type

1.2.1 Global Women's Health Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Postmenopausal Osteoporosis Drug

1.2.3 Infertility Drug

1.2.4 Endometriosis Drug

1.2.5 Contraceptives Drug

1.2.6 Menopause Drug

1.2.7 Polycystic Ovary Syndrome Drug

1.2.8 Other

1.3 Market by Application

1.3.1 Global Women's Health Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Little Girls

1.3.3 Young Women

1.3.4 Elderly Women

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Women's Health Drugs Sales Estimates and Forecasts 2018-2029

2.2 Global Women's Health Drugs Revenue by Region

2.2.1 Global Women's Health Drugs Revenue by Region: 2018 VS 2022 VS 2029

2.2.2 Global Women's Health Drugs Revenue by Region (2018-2023)

2.2.3 Global Women's Health Drugs Revenue by Region (2024-2029)

2.2.4 Global Women's Health Drugs Revenue Market Share by Region (2018-2029)

2.3 Global Women's Health Drugs Sales Estimates and Forecasts 2018-2029

2.4 Global Women's Health Drugs Sales by Region

2.4.1 Global Women's Health Drugs Sales by Region: 2018 VS 2022 VS 2029

2.4.2 Global Women's Health Drugs Sales by Region (2018-2023)

2.4.3 Global Women's Health Drugs Sales by Region (2024-2029)

2.4.4 Global Women's Health Drugs Sales Market Share by Region (2018-2029)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Women's Health Drugs Sales by Manufacturers

3.1.1 Global Women's Health Drugs Sales by Manufacturers (2018-2023)

3.1.2 Global Women's Health Drugs Sales Market Share by Manufacturers (2018-2023)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Women's Health Drugs in 2022

3.2 Global Women's Health Drugs Revenue by Manufacturers

3.2.1 Global Women's Health Drugs Revenue by Manufacturers (2018-2023)

3.2.2 Global Women's Health Drugs Revenue Market Share by Manufacturers (2018-2023)

3.2.3 Global Top 10 and Top 5 Companies by Women's Health Drugs Revenue in 2022

3.3 Global Key Players of Women's Health Drugs, Industry Ranking, 2021 VS 2022 VS 2023

3.4 Global Women's Health Drugs Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Women's Health Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Women's Health Drugs, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Women's Health Drugs, Product Offered and Application

3.8 Global Key Manufacturers of Women's Health Drugs, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Women's Health Drugs Sales by Type

4.1.1 Global Women's Health Drugs Historical Sales by Type (2018-2023)

4.1.2 Global Women's Health Drugs Forecasted Sales by Type (2024-2029)

4.1.3 Global Women's Health Drugs Sales Market Share by Type (2018-2029)

4.2 Global Women's Health Drugs Revenue by Type

4.2.1 Global Women's Health Drugs Historical Revenue by Type (2018-2023)

4.2.2 Global Women's Health Drugs Forecasted Revenue by Type (2024-2029)

4.2.3 Global Women's Health Drugs Revenue Market Share by Type (2018-2029)

4.3 Global Women's Health Drugs Price by Type

4.3.1 Global Women's Health Drugs Price by Type (2018-2023)

4.3.2 Global Women's Health Drugs Price Forecast by Type (2024-2029)

5 Market Size by Application

5.1 Global Women's Health Drugs Sales by Application

5.1.1 Global Women's Health Drugs Historical Sales by Application (2018-2023)

5.1.2 Global Women's Health Drugs Forecasted Sales by Application (2024-2029)

5.1.3 Global Women's Health Drugs Sales Market Share by Application (2018-2029)

5.2 Global Women's Health Drugs Revenue by Application

5.2.1 Global Women's Health Drugs Historical Revenue by Application (2018-2023)

5.2.2 Global Women's Health Drugs Forecasted Revenue by Application (2024-2029)

5.2.3 Global Women's Health Drugs Revenue Market Share by Application (2018-2029)

5.3 Global Women's Health Drugs Price by Application

5.3.1 Global Women's Health Drugs Price by Application (2018-2023)

5.3.2 Global Women's Health Drugs Price Forecast by Application (2024-2029)

6 US & Canada

6.1 US & Canada Women's Health Drugs Market Size by Type

6.1.1 US & Canada Women's Health Drugs Sales by Type (2018-2029)

6.1.2 US & Canada Women's Health Drugs Revenue by Type (2018-2029)

6.2 US & Canada Women's Health Drugs Market Size by Application

6.2.1 US & Canada Women's Health Drugs Sales by Application (2018-2029)

6.2.2 US & Canada Women's Health Drugs Revenue by Application (2018-2029)

6.3 US & Canada Women's Health Drugs Market Size by Country

6.3.1 US & Canada Women's Health Drugs Revenue by Country: 2018 VS 2022 VS 2029

6.3.2 US & Canada Women's Health Drugs Sales by Country (2018-2029)

6.3.3 US & Canada Women's Health Drugs Revenue by Country (2018-2029)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Women's Health Drugs Market Size by Type

7.1.1 Europe Women's Health Drugs Sales by Type (2018-2029)

7.1.2 Europe Women's Health Drugs Revenue by Type (2018-2029)

7.2 Europe Women's Health Drugs Market Size by Application

7.2.1 Europe Women's Health Drugs Sales by Application (2018-2029)

7.2.2 Europe Women's Health Drugs Revenue by Application (2018-2029)

7.3 Europe Women's Health Drugs Market Size by Country

7.3.1 Europe Women's Health Drugs Revenue by Country: 2018 VS 2022 VS 2029

7.3.2 Europe Women's Health Drugs Sales by Country (2018-2029)

7.3.3 Europe Women's Health Drugs Revenue by Country (2018-2029)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Women's Health Drugs Market Size

8.1.1 China Women's Health Drugs Sales (2018-2029)

8.1.2 China Women's Health Drugs Revenue (2018-2029)

8.2 China Women's Health Drugs Market Size by Application

8.2.1 China Women's Health Drugs Sales by Application (2018-2029)

8.2.2 China Women's Health Drugs Revenue by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Women's Health Drugs Market Size by Type

9.1.1 Asia Women's Health Drugs Sales by Type (2018-2029)

9.1.2 Asia Women's Health Drugs Revenue by Type (2018-2029)

9.2 Asia Women's Health Drugs Market Size by Application

9.2.1 Asia Women's Health Drugs Sales by Application (2018-2029)

9.2.2 Asia Women's Health Drugs Revenue by Application (2018-2029)

9.3 Asia Women's Health Drugs Sales by Region

9.3.1 Asia Women's Health Drugs Revenue by Region: 2018 VS 2022 VS 2029

9.3.2 Asia Women's Health Drugs Revenue by Region (2018-2029)

9.3.3 Asia Women's Health Drugs Sales by Region (2018-2029)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Women's Health Drugs Market Size by Type

10.1.1 Middle East, Africa and Latin America Women's Health Drugs Sales by Type (2018-2029)

10.1.2 Middle East, Africa and Latin America Women's Health Drugs Revenue by Type (2018-2029)

10.2 Middle East, Africa and Latin America Women's Health Drugs Market Size by Application

10.2.1 Middle East, Africa and Latin America Women's Health Drugs Sales by Application (2018-2029)

10.2.2 Middle East, Africa and Latin America Women's Health Drugs Revenue by Application (2018-2029)

10.3 Middle East, Africa and Latin America Women's Health Drugs Sales by Country

10.3.1 Middle East, Africa and Latin America Women's Health Drugs Revenue by Country: 2018 VS 2022 VS 2029

10.3.2 Middle East, Africa and Latin America Women's Health Drugs Revenue by Country (2018-2029)

10.3.3 Middle East, Africa and Latin America Women's Health Drugs Sales by Country (2018-2029)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 AbbVie Inc

11.1.1 AbbVie Inc Company Information

11.1.2 AbbVie Inc Overview

11.1.3 AbbVie Inc Women's Health Drugs Sales, Price, Revenue and Gross Margin (2018-2023)

11.1.4 AbbVie Inc Women's Health Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 AbbVie Inc Recent Developments

11.2 Allergan Plc

11.2.1 Allergan Plc Company Information

11.2.2 Allergan Plc Overview

11.2.3 Allergan Plc Women's Health Drugs Sales, Price, Revenue and Gross Margin (2018-2023)

11.2.4 Allergan Plc Women's Health Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Allergan Plc Recent Developments

11.3 Bayer AG

11.3.1 Bayer AG Company Information

11.3.2 Bayer AG Overview

11.3.3 Bayer AG Women's Health Drugs Sales, Price, Revenue and Gross Margin (2018-2023)

11.3.4 Bayer AG Women's Health Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Bayer AG Recent Developments

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Information

11.4.2 GlaxoSmithKline Overview

11.4.3 GlaxoSmithKline Women's Health Drugs Sales, Price, Revenue and Gross Margin (2018-2023)

11.4.4 GlaxoSmithKline Women's Health Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 GlaxoSmithKline Recent Developments

11.5 Merck & Co.

11.5.1 Merck & Co. Company Information

11.5.2 Merck & Co. Overview

11.5.3 Merck & Co. Women's Health Drugs Sales, Price, Revenue and Gross Margin (2018-2023)

11.5.4 Merck & Co. Women's Health Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Merck & Co. Recent Developments

11.6 Pfizer

11.6.1 Pfizer Company Information

11.6.2 Pfizer Overview

11.6.3 Pfizer Women's Health Drugs Sales, Price, Revenue and Gross Margin (2018-2023)

11.6.4 Pfizer Women's Health Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Pfizer Recent Developments

11.7 Therapeutics MD

11.7.1 Therapeutics MD Company Information

11.7.2 Therapeutics MD Overview

11.7.3 Therapeutics MD Women's Health Drugs Sales, Price, Revenue and Gross Margin (2018-2023)

11.7.4 Therapeutics MD Women's Health Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Therapeutics MD Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Women's Health Drugs Industry Chain Analysis

12.2 Women's Health Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Women's Health Drugs Production Mode & Process

12.4 Women's Health Drugs Sales and Marketing

12.4.1 Women's Health Drugs Sales Channels

12.4.2 Women's Health Drugs Distributors

12.5 Women's Health Drugs Customers

13 Market Dynamics

13.1 Women's Health Drugs Industry Trends

13.2 Women's Health Drugs Market Drivers

13.3 Women's Health Drugs Market Challenges

13.4 Women's Health Drugs Market Restraints

14 Key Findings in The Global Women's Health Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Women's Health Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Table 2. Major Manufacturers of Postmenopausal Osteoporosis Drug

Table 3. Major Manufacturers of Infertility Drug

Table 4. Major Manufacturers of Endometriosis Drug

Table 5. Major Manufacturers of Contraceptives Drug

Table 6. Major Manufacturers of Menopause Drug

Table 7. Major Manufacturers of Polycystic Ovary Syndrome Drug

Table 8. Major Manufacturers of Other

Table 9. Global Women's Health Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Women's Health Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 11. Global Women's Health Drugs Revenue by Region (2018-2023) & (US$ Million)

Table 12. Global Women's Health Drugs Revenue by Region (2024-2029) & (US$ Million)

Table 13. Global Women's Health Drugs Revenue Market Share by Region (2018-2023)

Table 14. Global Women's Health Drugs Revenue Market Share by Region (2024-2029)

Table 15. Global Women's Health Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 16. Global Women's Health Drugs Sales by Region (2018-2023) & (K MT)

Table 17. Global Women's Health Drugs Sales by Region (2024-2029) & (K MT)

Table 18. Global Women's Health Drugs Sales Market Share by Region (2018-2023)

Table 19. Global Women's Health Drugs Sales Market Share by Region (2024-2029)

Table 20. Global Women's Health Drugs Sales by Manufacturers (2018-2023) & (K MT)

Table 21. Global Women's Health Drugs Sales Share by Manufacturers (2018-2023)

Table 22. Global Women's Health Drugs Revenue by Manufacturers (2018-2023) & (US$ Million)

Table 23. Global Women's Health Drugs Revenue Share by Manufacturers (2018-2023)

Table 24. Global Key Players of Women's Health Drugs, Industry Ranking, 2021 VS 2022 VS 2023

Table 25. Women's Health Drugs Price by Manufacturers 2018-2023 (USD/Kg)

Table 26. Global Women's Health Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 27. Global Women's Health Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Women's Health Drugs as of 2022)

Table 28. Global Key Manufacturers of Women's Health Drugs, Manufacturing Base Distribution and Headquarters

Table 29. Global Key Manufacturers of Women's Health Drugs, Product Offered and Application

Table 30. Global Key Manufacturers of Women's Health Drugs, Date of Enter into This Industry

Table 31. Mergers & Acquisitions, Expansion Plans

Table 32. Global Women's Health Drugs Sales by Type (2018-2023) & (K MT)

Table 33. Global Women's Health Drugs Sales by Type (2024-2029) & (K MT)

Table 34. Global Women's Health Drugs Sales Share by Type (2018-2023)

Table 35. Global Women's Health Drugs Sales Share by Type (2024-2029)

Table 36. Global Women's Health Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 37. Global Women's Health Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 38. Global Women's Health Drugs Revenue Share by Type (2018-2023)

Table 39. Global Women's Health Drugs Revenue Share by Type (2024-2029)

Table 40. Women's Health Drugs Price by Type (2018-2023) & (USD/Kg)

Table 41. Global Women's Health Drugs Price Forecast by Type (2024-2029) & (USD/Kg)

Table 42. Global Women's Health Drugs Sales by Application (2018-2023) & (K MT)

Table 43. Global Women's Health Drugs Sales by Application (2024-2029) & (K MT)

Table 44. Global Women's Health Drugs Sales Share by Application (2018-2023)

Table 45. Global Women's Health Drugs Sales Share by Application (2024-2029)

Table 46. Global Women's Health Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 47. Global Women's Health Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 48. Global Women's Health Drugs Revenue Share by Application (2018-2023)

Table 49. Global Women's Health Drugs Revenue Share by Application (2024-2029)

Table 50. Women's Health Drugs Price by Application (2018-2023) & (USD/Kg)

Table 51. Global Women's Health Drugs Price Forecast by Application (2024-2029) & (USD/Kg)

Table 52. US & Canada Women's Health Drugs Sales by Type (2018-2023) & (K MT)

Table 53. US & Canada Women's Health Drugs Sales by Type (2024-2029) & (K MT)

Table 54. US & Canada Women's Health Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 55. US & Canada Women's Health Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 56. US & Canada Women's Health Drugs Sales by Application (2018-2023) & (K MT)

Table 57. US & Canada Women's Health Drugs Sales by Application (2024-2029) & (K MT)

Table 58. US & Canada Women's Health Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 59. US & Canada Women's Health Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 60. US & Canada Women's Health Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 61. US & Canada Women's Health Drugs Revenue by Country (2018-2023) & (US$ Million)

Table 62. US & Canada Women's Health Drugs Revenue by Country (2024-2029) & (US$ Million)

Table 63. US & Canada Women's Health Drugs Sales by Country (2018-2023) & (K MT)

Table 64. US & Canada Women's Health Drugs Sales by Country (2024-2029) & (K MT)

Table 65. Europe Women's Health Drugs Sales by Type (2018-2023) & (K MT)

Table 66. Europe Women's Health Drugs Sales by Type (2024-2029) & (K MT)

Table 67. Europe Women's Health Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 68. Europe Women's Health Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 69. Europe Women's Health Drugs Sales by Application (2018-2023) & (K MT)

Table 70. Europe Women's Health Drugs Sales by Application (2024-2029) & (K MT)

Table 71. Europe Women's Health Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 72. Europe Women's Health Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 73. Europe Women's Health Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 74. Europe Women's Health Drugs Revenue by Country (2018-2023) & (US$ Million)

Table 75. Europe Women's Health Drugs Revenue by Country (2024-2029) & (US$ Million)

Table 76. Europe Women's Health Drugs Sales by Country (2018-2023) & (K MT)

Table 77. Europe Women's Health Drugs Sales by Country (2024-2029) & (K MT)

Table 78. China Women's Health Drugs Sales by Type (2018-2023) & (K MT)

Table 79. China Women's Health Drugs Sales by Type (2024-2029) & (K MT)

Table 80. China Women's Health Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 81. China Women's Health Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 82. China Women's Health Drugs Sales by Application (2018-2023) & (K MT)

Table 83. China Women's Health Drugs Sales by Application (2024-2029) & (K MT)

Table 84. China Women's Health Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 85. China Women's Health Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 86. Asia Women's Health Drugs Sales by Type (2018-2023) & (K MT)

Table 87. Asia Women's Health Drugs Sales by Type (2024-2029) & (K MT)

Table 88. Asia Women's Health Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 89. Asia Women's Health Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 90. Asia Women's Health Drugs Sales by Application (2018-2023) & (K MT)

Table 91. Asia Women's Health Drugs Sales by Application (2024-2029) & (K MT)

Table 92. Asia Women's Health Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 93. Asia Women's Health Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 94. Asia Women's Health Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 95. Asia Women's Health Drugs Revenue by Region (2018-2023) & (US$ Million)

Table 96. Asia Women's Health Drugs Revenue by Region (2024-2029) & (US$ Million)

Table 97. Asia Women's Health Drugs Sales by Region (2018-2023) & (K MT)

Table 98. Asia Women's Health Drugs Sales by Region (2024-2029) & (K MT)

Table 99. Middle East, Africa and Latin America Women's Health Drugs Sales by Type (2018-2023) & (K MT)

Table 100. Middle East, Africa and Latin America Women's Health Drugs Sales by Type (2024-2029) & (K MT)

Table 101. Middle East, Africa and Latin America Women's Health Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 102. Middle East, Africa and Latin America Women's Health Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 103. Middle East, Africa and Latin America Women's Health Drugs Sales by Application (2018-2023) & (K MT)

Table 104. Middle East, Africa and Latin America Women's Health Drugs Sales by Application (2024-2029) & (K MT)

Table 105. Middle East, Africa and Latin America Women's Health Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 106. Middle East, Africa and Latin America Women's Health Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 107. Middle East, Africa and Latin America Women's Health Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 108. Middle East, Africa and Latin America Women's Health Drugs Revenue by Country (2018-2023) & (US$ Million)

Table 109. Middle East, Africa and Latin America Women's Health Drugs Revenue by Country (2024-2029) & (US$ Million)

Table 110. Middle East, Africa and Latin America Women's Health Drugs Sales by Country (2018-2023) & (K MT)

Table 111. Middle East, Africa and Latin America Women's Health Drugs Sales by Country (2024-2029) & (K MT)

Table 112. AbbVie Inc Company Information

Table 113. AbbVie Inc Description and Major Businesses

Table 114. AbbVie Inc Women's Health Drugs Sales (K MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 115. AbbVie Inc Women's Health Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. AbbVie Inc Recent Developments

Table 117. Allergan Plc Company Information

Table 118. Allergan Plc Description and Major Businesses

Table 119. Allergan Plc Women's Health Drugs Sales (K MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 120. Allergan Plc Women's Health Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Allergan Plc Recent Developments

Table 122. Bayer AG Company Information

Table 123. Bayer AG Description and Major Businesses

Table 124. Bayer AG Women's Health Drugs Sales (K MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 125. Bayer AG Women's Health Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Bayer AG Recent Developments

Table 127. GlaxoSmithKline Company Information

Table 128. GlaxoSmithKline Description and Major Businesses

Table 129. GlaxoSmithKline Women's Health Drugs Sales (K MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 130. GlaxoSmithKline Women's Health Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. GlaxoSmithKline Recent Developments

Table 132. Merck & Co. Company Information

Table 133. Merck & Co. Description and Major Businesses

Table 134. Merck & Co. Women's Health Drugs Sales (K MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 135. Merck & Co. Women's Health Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Merck & Co. Recent Developments

Table 137. Pfizer Company Information

Table 138. Pfizer Description and Major Businesses

Table 139. Pfizer Women's Health Drugs Sales (K MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 140. Pfizer Women's Health Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Pfizer Recent Developments

Table 142. Therapeutics MD Company Information

Table 143. Therapeutics MD Description and Major Businesses

Table 144. Therapeutics MD Women's Health Drugs Sales (K MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 145. Therapeutics MD Women's Health Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Therapeutics MD Recent Developments

Table 147. Key Raw Materials Lists

Table 148. Raw Materials Key Suppliers Lists

Table 149. Women's Health Drugs Distributors List

Table 150. Women's Health Drugs Customers List

Table 151. Women's Health Drugs Market Trends

Table 152. Women's Health Drugs Market Drivers

Table 153. Women's Health Drugs Market Challenges

Table 154. Women's Health Drugs Market Restraints

Table 155. Research Programs/Design for This Report

Table 156. Key Data Information from Secondary Sources

Table 157. Key Data Information from Primary Sources

List of Figures

Figure 1. Women's Health Drugs Product Picture

Figure 2. Global Women's Health Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Women's Health Drugs Market Share by Type in 2022 & 2029

Figure 4. Postmenopausal Osteoporosis Drug Product Picture

Figure 5. Infertility Drug Product Picture

Figure 6. Endometriosis Drug Product Picture

Figure 7. Contraceptives Drug Product Picture

Figure 8. Menopause Drug Product Picture

Figure 9. Polycystic Ovary Syndrome Drug Product Picture

Figure 10. Other Product Picture

Figure 11. Global Women's Health Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 12. Global Women's Health Drugs Market Share by Application in 2022 & 2029

Figure 13. Little Girls

Figure 14. Young Women

Figure 15. Elderly Women

Figure 16. Women's Health Drugs Report Years Considered

Figure 17. Global Women's Health Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 18. Global Women's Health Drugs Revenue 2018-2029 (US$ Million)

Figure 19. Global Women's Health Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029

Figure 20. Global Women's Health Drugs Revenue Market Share by Region (2018-2029)

Figure 21. Global Women's Health Drugs Sales 2018-2029 ((K MT)

Figure 22. Global Women's Health Drugs Sales Market Share by Region (2018-2029)

Figure 23. US & Canada Women's Health Drugs Sales YoY (2018-2029) & (K MT)

Figure 24. US & Canada Women's Health Drugs Revenue YoY (2018-2029) & (US$ Million)

Figure 25. Europe Women's Health Drugs Sales YoY (2018-2029) & (K MT)

Figure 26. Europe Women's Health Drugs Revenue YoY (2018-2029) & (US$ Million)

Figure 27. China Women's Health Drugs Sales YoY (2018-2029) & (K MT)

Figure 28. China Women's Health Drugs Revenue YoY (2018-2029) & (US$ Million)

Figure 29. Asia (excluding China) Women's Health Drugs Sales YoY (2018-2029) & (K MT)

Figure 30. Asia (excluding China) Women's Health Drugs Revenue YoY (2018-2029) & (US$ Million)

Figure 31. Middle East, Africa and Latin America Women's Health Drugs Sales YoY (2018-2029) & (K MT)

Figure 32. Middle East, Africa and Latin America Women's Health Drugs Revenue YoY (2018-2029) & (US$ Million)

Figure 33. The Women's Health Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022

Figure 34. The Top 5 and 10 Largest Manufacturers of Women's Health Drugs in the World: Market Share by Women's Health Drugs Revenue in 2022

Figure 35. Global Women's Health Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 36. Global Women's Health Drugs Sales Market Share by Type (2018-2029)

Figure 37. Global Women's Health Drugs Revenue Market Share by Type (2018-2029)

Figure 38. Global Women's Health Drugs Sales Market Share by Application (2018-2029)

Figure 39. Global Women's Health Drugs Revenue Market Share by Application (2018-2029)

Figure 40. US & Canada Women's Health Drugs Sales Market Share by Type (2018-2029)

Figure 41. US & Canada Women's Health Drugs Revenue Market Share by Type (2018-2029)

Figure 42. US & Canada Women's Health Drugs Sales Market Share by Application (2018-2029)

Figure 43. US & Canada Women's Health Drugs Revenue Market Share by Application (2018-2029)

Figure 44. US & Canada Women's Health Drugs Revenue Share by Country (2018-2029)

Figure 45. US & Canada Women's Health Drugs Sales Share by Country (2018-2029)

Figure 46. U.S. Women's Health Drugs Revenue (2018-2029) & (US$ Million)

Figure 47. Canada Women's Health Drugs Revenue (2018-2029) & (US$ Million)

Figure 48. Europe Women's Health Drugs Sales Market Share by Type (2018-2029)

Figure 49. Europe Women's Health Drugs Revenue Market Share by Type (2018-2029)

Figure 50. Europe Women's Health Drugs Sales Market Share by Application (2018-2029)

Figure 51. Europe Women's Health Drugs Revenue Market Share by Application (2018-2029)

Figure 52. Europe Women's Health Drugs Revenue Share by Country (2018-2029)

Figure 53. Europe Women's Health Drugs Sales Share by Country (2018-2029)

Figure 54. Germany Women's Health Drugs Revenue (2018-2029) & (US$ Million)

Figure 55. France Women's Health Drugs Revenue (2018-2029) & (US$ Million)

Figure 56. U.K. Women's Health Drugs Revenue (2018-2029) & (US$ Million)

Figure 57. Italy Women's Health Drugs Revenue (2018-2029) & (US$ Million)

Figure 58. Russia Women's Health Drugs Revenue (2018-2029) & (US$ Million)

Figure 59. China Women's Health Drugs Sales Market Share by Type (2018-2029)

Figure 60. China Women's Health Drugs Revenue Market Share by Type (2018-2029)

Figure 61. China Women's Health Drugs Sales Market Share by Application (2018-2029)

Figure 62. China Women's Health Drugs Revenue Market Share by Application (2018-2029)

Figure 63. Asia Women's Health Drugs Sales Market Share by Type (2018-2029)

Figure 64. Asia Women's Health Drugs Revenue Market Share by Type (2018-2029)

Figure 65. Asia Women's Health Drugs Sales Market Share by Application (2018-2029)

Figure 66. Asia Women's Health Drugs Revenue Market Share by Application (2018-2029)

Figure 67. Asia Women's Health Drugs Revenue Share by Region (2018-2029)

Figure 68. Asia Women's Health Drugs Sales Share by Region (2018-2029)

Figure 69. Japan Women's Health Drugs Revenue (2018-2029) & (US$ Million)

Figure 70. South Korea Women's Health Drugs Revenue (2018-2029) & (US$ Million)

Figure 71. China Taiwan Women's Health Drugs Revenue (2018-2029) & (US$ Million)

Figure 72. Southeast Asia Women's Health Drugs Revenue (2018-2029) & (US$ Million)

Figure 73. India Women's Health Drugs Revenue (2018-2029) & (US$ Million)

Figure 74. Middle East, Africa and Latin America Women's Health Drugs Sales Market Share by Type (2018-2029)

Figure 75. Middle East, Africa and Latin America Women's Health Drugs Revenue Market Share by Type (2018-2029)

Figure 76. Middle East, Africa and Latin America Women's Health Drugs Sales Market Share by Application (2018-2029)

Figure 77. Middle East, Africa and Latin America Women's Health Drugs Revenue Market Share by Application (2018-2029)

Figure 78. Middle East, Africa and Latin America Women's Health Drugs Revenue Share by Country (2018-2029)

Figure 79. Middle East, Africa and Latin America Women's Health Drugs Sales Share by Country (2018-2029)

Figure 80. Brazil Women's Health Drugs Revenue (2018-2029) & (US$ Million)

Figure 81. Mexico Women's Health Drugs Revenue (2018-2029) & (US$ Million)

Figure 82. Turkey Women's Health Drugs Revenue (2018-2029) & (US$ Million)

Figure 83. Israel Women's Health Drugs Revenue (2018-2029) & (US$ Million)

Figure 84. GCC Countries Women's Health Drugs Revenue (2018-2029) & (US$ Million)

Figure 85. Women's Health Drugs Value Chain

Figure 86. Women's Health Drugs Production Process

Figure 87. Channels of Distribution

Figure 88. Distributors Profiles

Figure 89. Bottom-up and Top-down Approaches for This Report

Figure 90. Data Triangulation

Figure 91. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Endoparasiticide Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36H8345

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34R905

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global SGLT2 Inhibitor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2R9930

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34L14446

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions